Pillar Pacific Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Pillar Pacific Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,400	Closed	-$57K	–	303
2015 Q3	$57K	Hold	11,400	–	–	0.01%	287
2015 Q2	$73K	Hold	11,400	–	–	0.01%	286
2015 Q1	$80K	Sell	11,400 -400	-3%	-$2.9K	0.01%	284
2014 Q4	$91K	Hold	11,800	–	–	0.02%	282
2014 Q3	$88K	Hold	11,800	–	–	0.02%	298
2014 Q2	$115K	Hold	11,800	–	–	0.02%	294
2014 Q1	$98K	Hold	11,800	–	–	0.02%	288
2013 Q4	$99K	Hold	11,800	–	–	0.02%	300
2013 Q3	$94K	Hold	11,800	–	–	0.02%	289
2013 Q2	$91K	Buy	+11,800	New	+$92K	0.02%	292

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pillar Pacific Capital Management's PDLI Position: Q4 2015 in Review

Pillar Pacific Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 11,400 shares — an estimated $57K sold.

Pillar Pacific Capital Management first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $115K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Pillar Pacific Capital Management reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Pillar Pacific Capital Management sold 11,400 PDL BioPharma, Inc. shares in Q4 2015, an estimated $57K.
Pillar Pacific Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
Pillar Pacific Capital Management's PDL BioPharma, Inc. position peaked at $115K in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Pillar Pacific Capital Management's 13F filing for Q4 2015, filed 1 Feb 2016.